A case of thrombotic thrombocytopenic purpura with systemic lupus erythematosus

Japanese Journal of Clinical Immunology

Volumn 29, Issue 5, 2006, Pages 342-347

  Ogawa, Yayoi ^a   Mukai, Masaya ^a   Gotoh, Hideki ^a   Tanaka, Satoshi ^a   Takada, Akio ^a   Takenouchi, Toshinao ^a  

^a SAPPORO CITY GENERAL HOSPITAL   (Japan)

Author keywords

Autopsy; Plasmapheresis; SLE; TTP; Von Willebrand factor cleaving protease

Indexed keywords

ADAM PROTEIN; ADAMTS13 PROTEIN, HUMAN;

ARTICLE; CASE REPORT; FEMALE; HEART MUSCLE; HUMAN; KIDNEY; METABOLISM; MIDDLE AGED; PATHOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADAM PROTEINS; FEMALE; HUMANS; KIDNEY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; MYOCARDIUM; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

EID: 35348818309     PISSN: 09114300     EISSN: 13497413     Source Type: Journal    
DOI: 10.2177/jsci.29.342     Document Type: Article

References (14)

1. Furlan M., et al.: Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome. N Engl J Med 339: 1578–1584, 1998.
2. Tsai H-M, Lian EC-Y.: Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 339: 1585–1594, 1998.
3. Moschcowitz E.: Hyaline thrombosis of terminal arterioles and capillaries: A hitherto un-described disease. Proc NY Pathol Soc 24: 21–24, 1924.
4. Singer K., et al.: Thrombotic thrombocytopenic purpura. Blood 2: 542–554, 1947.
5. Hamasaki K., et al.: Systemic lupus erythematosus and thrombotic thrombocytopenic purpura: A case report and literature review. Clin Rheumatol 22: 355–358, 2003.
6. Starck M., et al.: Aquired thrombotic thrombocytopenic purpura as the presenting symptom of systemic lupus erythematosus. Successful treatment with plasma exchange and immunosuppression-report of two cases. Eur J Haemat 75: 436–440, 2005.
7. Yamazaki M.: Catastrophic antiphospholipid syndrome: CAPS. Jpn J Clin Immunol 28: 357–364, 2005.
8. Moake JL.: Thrombotic microangiopathies N Engl J Med 347: 589–600, 2002.
9. Wilson WA., et al.: International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arth Rheum 42: 1309–1311, 1992.
10. Weeing JJ., et al.: The classification of glomerulonephritis in systemic lupus erythromatosus revisited Kidney Int 65: 521–530, 2004.
11. Bell WR., et al.: Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med 325: 398–403, 1991.
12. Zheng XL., et al.: Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura. Blood 103: 4043–4049, 2004.
13. Vesely SK., et al.: ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: Relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood. 102: 60–68, 2003.
14. Rick ME., et al.: Clinical usefulness of a functional assay for the von Willebrand factor cleaving protease (ADAMTS 13) and its inhibitor in a patient with thrombotic thrombocytopenic purpura. Am J Hematol 75: 96–100, 2004.